screener development
Dotaz
Zobrazit nápovědu
Nejkritičtějším obdobím pro vývoj zraku jsou první 3 roky života dítěte, zejména prvních 12 měsíců života. V tomto období je zdravotní péče o dítě koordinována dětským lékařem nebo praktickým lékařem pro děti a dorost a záleží jen na nich, aby zajistili dnes už dostupný screeningový test. Ke screeningu zraku se používá přístroj na testování zraku Vision Screener na principu excentrické fotorefrakce s automatickým zhodnocením výsledků. První vyšetření by mělo být provedeno v období mezi 6. až 12. měsícem (optimálně mezi 10. až 12. měsícem) s kontrolním vyšetřením za 6 měsíců, tedy zpravidla do 18. měsíce věku dítěte. V případě pozitivního nálezu je dítě odesláno na vyšetření zrakové ostrosti k ortoptistovi nebo zrakovému terapeutovi a dále pak k očnímu lékaři. Screeningový test se provádí dvakrát za život v případě negativní rodinné anamnézy. Při pozitivní rodinné anamnéze závažných očních vad (tupozrakosti, strabismu, hypermetropie, krátkozrakosti, astigmatismu a jiných vrozených očních vad) se test opakuje ve 2. a 3. roce věku, maximálně 4× za život. Toto doporučení pokrývá všechna kritická období vývoje vidění dítěte a navazuje na systém péče o děti v ČR. Cílem koncepce včasného záchytu závažných očních vad je možnost korigovat patologické dioptrické hodnoty v tomto období, a zabránit tak poruše vývoje vidění a binokulárních funkcí. Čas, který ztratíme pozdním nebo nedokonalým stanovením diagnózy a nefunkčním léčebným plánem, je pro vývoj vidění kritický. Zahájení celonárodního screeningu zraku v ČR se plánuje již v roce 2025. Korespondující autorka: MUDr. Anna Zobanová Soukromá oční ordinace Praha ordinace.az@volny.cz
The first 3 years of a child‘s life, especially the first 12 months of life, are the most critical period for vision development. During this period, the child‘s health care is coordinated by a pediatrician or a general practitioner for children and adolescents, and it is up to them to provide the screening test that is now available. The vision screening uses a vision screener based on the principle of eccentric photorefraction with automatic evaluation of the results. The first examination should be performed between the 6th and 12th months (optimally between the 10th and 12th months of age) with a control examination after 6 months, i.e. usually by the 18th month of the child‘s age. If the result of this test is positive, the child is sent for an examination of visual acuity to an orthoptist or vision therapist and then to an ophthalmologist. The screennig test is carried out twice in a lifetime in the case of a negative family history. If there is a positive family history of serious eye defects (amblyopia, strabismus, hypermetropia, myopia, astigmatism and other congenital eye defects), the test is repeated in the 2nd and 3rd year of age, maximaly 4 times in a lifetime. This recommendation covers all critical periods of a child‘s vision development and follows the childcare system in the Czech Republic. The goal of the concept of early detection of serious eye defects is to have the possibility of correcting pathological dioptric values during this period and thus preventing impaired development of vision and binocular functions. The time lost due to a late or incomplete diagnosis and ineffective treatment plan is critical to the development of vision. The launch of nationwide vision screening in the Czech Republic is planned as early as in the next year (2025).
- MeSH
- dítě MeSH
- lidé MeSH
- refrakční vady * diagnóza prevence a kontrola MeSH
- screening zrakových vad * metody organizace a řízení přístrojové vybavení zákonodárství a právo MeSH
- Check Tag
- dítě MeSH
- lidé MeSH
- Publikační typ
- přehledy MeSH
Consumption of plant-based diets, including vegan diets, necessitates attention to the quality of the diet for the prevention and early detection of nutritional deficiencies. Within the VEGANScreener project, a unique brief screening tool for the assessment and monitoring of diet quality among vegans in Europe was developed. To provide a standardized tool for public use, a clinical study will be conducted to evaluate the VEGANScreener against a reference dietary assessment method and nutritional biomarkers. An observational study is set to include 600 participants across five European sites - Belgium, Czech Republic, Germany, Spain, and Switzerland. In total, 400 self-reported vegans (≥2 years on a vegan diet), and 170 self-reported omnivore controls will be examined, aged between 18 and 65 years, with males and females being equally represented in a 1:1 ratio for two age groups (18-35 and 36-65 years). Participants with diseases affecting metabolism and intestinal integrity will be excluded. The clinical assessment will include a structured medical history, along with taking blood pressure and anthropometric measurements. Blood and urine will be sampled and analyzed for a set of dietary biomarkers. Metabolomic analyses will be conducted to explore potential novel biomarkers of vegan diet. Moreover, saliva samples will be collected to assess the metabolome and the microbiome. Participants will receive instructions to complete a nonconsecutive 4-day diet record, along with the VEGANScreener, a socio-demographic survey, a well-being survey, and a FFQ. To evaluate reproducibility, the VEGANScreener will be administered twice over a three-weeks period. Among vegans, the construct validity and criterion validity of the VEGANScreener will be analyzed through associations of the score with nutrient and food group intakes, diet quality scores assessed from the 4-day diet records, and associations with the dietary biomarkers. Secondary outcomes will include analysis of dietary data, metabolomics, and microbiomes in all participants. Major nutrient sources and variations will be assessed in the sample. Exploratory metabolomic analysis will be performed using multivariable statistics and regression analysis to identify novel biomarkers. Standard statistical models will be implemented for cross-sectional comparisons of geographical groups and vegans versus omnivores.
- Publikační typ
- časopisecké články MeSH
BACKGROUND: Plant-based diets are not inherently healthy. Similar to omnivorous diets, they may contain excessive amounts of sugar, sodium, and saturated fats, or lack diversity. Moreover, vegans might be at risk of inadequate intake of certain vitamins and minerals commonly found in foods that they avoid. We developed the VEGANScreener, a tool designed to assess the diet quality of vegans in Europe. METHODS: Our approach combined best practices in developing diet quality metrics with scale development approaches and involved the following: (a) narrative literature synthesis, (b) evidence evaluation by an international panel of experts, and (c) translation of evidence into a diet screener. We employed a modified Delphi technique to gather opinions from an international expert panel. RESULTS: Twenty-five experts in the fields of nutrition, epidemiology, preventive medicine, and diet assessment participated in the first round, and nineteen participated in the subsequent round. Initially, these experts provided feedback on a pool of 38 proposed items from the literature review. Consequently, 35 revised items, with 17 having multiple versions, were suggested for further consideration. In the second round, 29 items were retained, and any residual issues were addressed in the final consensus meeting. The ultimate screener draft encompassed 29 questions, with 17 focusing on foods and nutrients to promote, and 12 addressing foods and nutrients to limit. The screener contained 24 food-based and 5 nutrient-based questions. CONCLUSIONS: We elucidated the development process of the VEGANScreener, a novel diet quality screener for vegans. Future endeavors involve contrasting the VEGANScreener against benchmark diet assessment methodologies and nutritional biomarkers and testing its acceptance. Once validated, this instrument holds potential for deployment as a self-assessment application for vegans and as a preliminary dietary screening and counseling tool in healthcare settings.
- MeSH
- delfská metoda MeSH
- dieta veganská * MeSH
- hodnocení stavu výživy MeSH
- lidé MeSH
- Check Tag
- lidé MeSH
- Publikační typ
- časopisecké články MeSH
- Geografické názvy
- Evropa MeSH
Background There is a scarcity of validated rapid dietary screening tools for patient use in the clinical setting to improve health and reduce cardiovascular risk. The Healthy Eating Index (HEI) 2015 measures compliance with the 2015 to 2020 Dietary Guidelines for Americans but requires completion of an extensive diet assessment to compute, which is time consuming and impractical. The authors hypothesize that a 19-item dietary survey assessing consumption of common food groups known to affect health will be correlated with the HEI-2015 assessed by a validated food frequency questionnaire and can be further reduced without affecting validity. Methods and Results A 19-item Eating Assessment Tool (EAT) of common food groups was created through literature review and expert consensus. A cross-sectional survey was then conducted in adult participants from a preventive cardiology clinic or cardiac rehabilitation and in healthy volunteers (n=661, mean age, 36 years; 76% women). Participants completed an online 156-item food frequency questionnaire, which was used to calculate the HEI score using standard methods. The association between each EAT question and HEI group was analyzed by Kruskal-Wallis test. Linear regression models were subsequently used to identify univariable and multivariable predictors for HEI score for further reduction in the number of items. The final 9-item model of Mini-EAT was validated by 5-fold cross validation. The 19-item EAT had a strong correlation with the HEI score (r=0.73) and was subsequently reduced to the 9 items independently predictive of the HEI score: fruits, vegetables, whole grains, refined grains, fish or seafood, legumes/nuts/seeds, low-fat dairy, high-fat dairy, and sweets consumption, without affecting the predictive ability of the tool (r=0.71). Conclusions Mini-EAT is a 9-item validated brief dietary screener that correlates well with a comprehensive food frequency questionnaire. Future studies to test the Mini-EAT's validity in diverse populations and for development of clinical decision support systems to capture changes over time are needed.
- MeSH
- dieta * MeSH
- ovoce MeSH
- průřezové studie MeSH
- průzkumy a dotazníky MeSH
- zelenina * MeSH
- zvířata MeSH
- Check Tag
- zvířata MeSH
- Publikační typ
- časopisecké články MeSH
Negative experiences in school predict adolescents' depression. However, the dynamic interactions of depressive symptoms with adolescents' negative experiences in school remain unclear. This study aimed to applied network analysis to detect the complex relationships between early adolescents' depressive symptoms and negative experiences in school. We adopted the data from a Chinese national survey conducted in 2018. Eight hundred ninety-seven adolescents from 10 to 15 years old were included. The measurements included an 8-item depression screener scale and a 14-item scale assessing negative experiences in school. The centrality analysis suggested that Chinese early adolescents' core depressive symptoms were negative affections. Regarding "negative experiences in the school," the most central nodes were poor academic performance and peer relationships. The bridge-centrality results showed negative emotions in school and difficulties in peer relationships were significantly linked to depression. Educators should pay attention to adolescents' negative affection and difficulties in peer relationships in school settings because they are potential signs of depression. Relevant peer support intervention aiming for adolescents' social development should be underscored.
Background: Empirical soundness and international robustness of the PID5BF+M, a shortened version of the PID-5 developed for simultaneous evaluation of maladaptive personality traits in the DSM-5 AMPD and ICD-11 models for personality disorders, was recently confirmed in 16 samples from different countries. Because the modified PID5BF+ scale (36 items) was extracted from the complete 220-item PID-5, an independent evaluation of psychometric properties of a stand-alone PID5BF+M is still missing. Objectives: The present study evaluated the validity and reliability of the 36-item PID5BF+M in comparison with the extracted version from the original PID-5. It also assessed associations between the Borderline Pattern qualifier and trait domain qualifiers. Methods: Two non-clinical samples meeting the inclusion criteria were employed in the study. Sample 1 (n = 614) completed the 220-item PID-5; Sample 2 (n = 1,040) completed the independent 36-item PID5BF+M. Participants were from all 14 regions of the Czech Republic. The Borderline Pattern qualifier was evaluated using a shortened IPDEQ screener. Results: The proposed latent structure of the independent PID5BF+M was confirmed, with an exception of the Disinhibition domain. The results confirmed good internal consistency and test-retest reliability of the measure, as well as some support for the measurement invariance of the independent PID5BF+M in comparison with the extracted version from the original PID-5. Significant associations between the Negative affectivity, Disinhibition, and Psychoticism qualifiers and the IPDEQ items for the emotionally unstable personality disorder of both impulsive and borderline types confirmed good predictive validity of the PID5BF+M in pursuing borderline psychopathology within the ICD-11 model. Conclusions: The independent PID5BF+M was found to be a valid and reliable tool for evaluation of the ICD-11 trait model. However, the Disinhibition domain deserves further investigation in clinical samples as well as in international community samples.
- Publikační typ
- časopisecké články MeSH
AIM: The purpose of this study was to develop a revised version of the Brief Bedside Dysphagia Screening Test for determining penetration/aspiration risk in patients prone to dysphagia. The priority was to achieve high sensitivity and negative predictive value. METHODS: The study screeners conducted bedside assessment of the swallowing function in 157 patients with a neurological (mainly stroke) or an ear, nose, and throat diagnosis (mainly head and neck cancer). The results were compared with a gold standard, flexible endoscopic examination of swallowing. RESULTS: For the neurological subgroup (N = 106), eight statistically significant bedside assessment items were combined into the Brief Bedside Dysphagia Screening Test-Revised (BBDST-R). Cut-off score 1 produced the highest sensitivity (95.5%; 95% confidence interval CI [CI]: 84.9-98.7%) and negative predictive value (88.9%; 95% CI 67.2-96.9%). CONCLUSION: The BBDST-R is suitable for dysphagia screening in departments caring for patients with neurological conditions.
- MeSH
- cévní mozková příhoda komplikace MeSH
- lidé středního věku MeSH
- lidé MeSH
- otorinolaryngologické nemoci komplikace MeSH
- plošný screening metody MeSH
- point of care testing * MeSH
- polykání MeSH
- poruchy polykání diagnóza etiologie MeSH
- průřezové studie MeSH
- reprodukovatelnost výsledků MeSH
- senioři MeSH
- určení symptomu metody MeSH
- Check Tag
- lidé středního věku MeSH
- lidé MeSH
- mužské pohlaví MeSH
- senioři MeSH
- ženské pohlaví MeSH
- Publikační typ
- časopisecké články MeSH
- práce podpořená grantem MeSH
- Geografické názvy
- Česká republika MeSH
INTRODUCTION: Cannabis is Europe's most commonly used illicit drug. Some users do not develop dependence or other problems, whereas others do. Many factors are associated with the occurrence of cannabis-related disorders. This makes it difficult to identify key risk factors and markers to profile at-risk cannabis users using traditional hypothesis-driven approaches. Therefore, the use of a data-mining technique called binary recursive partitioning is demonstrated in this study by creating a classification tree to profile at-risk users. METHODS: 59 variables on cannabis use and drug market experiences were extracted from an internet-based survey dataset collected in four European countries (Czech Republic, Italy, Netherlands and Sweden), n = 2617. These 59 potential predictors of problematic cannabis use were used to partition individual respondents into subgroups with low and high risk of having a cannabis use disorder, based on their responses on the Cannabis Abuse Screening Test. Both a generic model for the four countries combined and four country-specific models were constructed. RESULTS: Of the 59 variables included in the first analysis step, only three variables were required to construct a generic partitioning model to classify high risk cannabis users with 65-73% accuracy. Based on the generic model for the four countries combined, the highest risk for cannabis use disorder is seen in participants reporting a cannabis use on more than 200 days in the last 12 months. In comparison to the generic model, the country-specific models led to modest, non-significant improvements in classification accuracy, with an exception for Italy (p = 0.01). CONCLUSION: Using recursive partitioning, it is feasible to construct classification trees based on only a few variables with acceptable performance to classify cannabis users into groups with low or high risk of meeting criteria for cannabis use disorder. The number of cannabis use days in the last 12 months is the most relevant variable. The identified variables may be considered for use in future screeners for cannabis use disorders.
- MeSH
- abúzus marihuany epidemiologie MeSH
- dospělí MeSH
- kanabinoidy farmakologie MeSH
- kouření marihuany epidemiologie MeSH
- lidé MeSH
- mladý dospělý MeSH
- multivariační analýza MeSH
- odhalování abúzu drog metody MeSH
- poruchy spojené s užíváním kokainu epidemiologie MeSH
- riziko MeSH
- sběr dat MeSH
- Check Tag
- dospělí MeSH
- lidé MeSH
- mladý dospělý MeSH
- mužské pohlaví MeSH
- ženské pohlaví MeSH
- Publikační typ
- časopisecké články MeSH
- práce podpořená grantem MeSH
- Geografické názvy
- Česká republika MeSH
- Itálie MeSH
- Nizozemsko MeSH
- Švédsko MeSH
In patients who are prone to impaired swallowing, dysphagia screening has been advocated. However, most dysphagia screening tests are lacking gold-standard validation and nurse screeners. The purpose of this study was to develop a nursing dysphagia screening test to determine the penetration or aspiration risk in patients with neurological and ear, nose, and throat conditions. Eighty-seven Czech patients underwent a bedside assessment by nurse screeners. A comparison of the results to the gold standard, flexible endoscopic examination of swallowing, identified eight "important" or "marginal" assessment items, which were combined into one test, called the Brief Bedside Dysphagia Screening Test: "ability to clench the teeth"; "symmetry/strength of the tongue"; "symmetry/strength of the facial muscles"; "symmetry/strength of the shoulder shrug"; "dysarthria"; "thick liquid: choking"; "thick liquid: dripping from the mouth"; and "thick liquid: cough". The sensitivity, specificity, and negative predictive value of the Brief Bedside Dysphagia Screening Test were: 87.1%, 30.4%, and 81%, respectively, in all patients; 95.2%, 27.5%, and 93.3%, respectively, in patients with neurological conditions; and 60%, 60%, and 42.9%, respectively, in patients with ear, nose, and throat conditions. The test is more suitable for patients with neurological conditions than for more heterogeneous patient populations.
- MeSH
- audiovizuální záznam přístrojové vybavení MeSH
- fluoroskopie přístrojové vybavení metody MeSH
- hodnocení rizik metody MeSH
- interval spolehlivosti MeSH
- lidé MeSH
- polykání MeSH
- poruchy polykání diagnóza ošetřování MeSH
- prediktivní hodnota testů MeSH
- senioři MeSH
- senzitivita a specificita MeSH
- ukazatele zdravotního stavu MeSH
- vyšetření u lůžka MeSH
- Check Tag
- lidé MeSH
- mužské pohlaví MeSH
- senioři MeSH
- ženské pohlaví MeSH
- Publikační typ
- časopisecké články MeSH
- srovnávací studie MeSH
- validační studie MeSH
- Geografické názvy
- Česká republika MeSH
